3-31-15 The effect of two different doses of ricombinant interferon beta-1a on relapses and total lesion volume in relapsing-remitting multiple sclerosis over the 24 month treatment period

1997 ◽  
Vol 150 ◽  
pp. S186
Author(s):  
T. Koudriavtseva ◽  
C. Pozzilli ◽  
S. Bastianello ◽  
C. Gasperini ◽  
S. Galgani ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Treatment Period ◽  
Interferon Beta ◽  
Lesion Volume ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis ◽  
Different Doses

Interferon-beta and disability progression in relapsing-remitting multiple sclerosis

2013 ◽  
Vol 115 ◽  
pp. S65-S69 ◽  
Author(s):  
Jelena Drulovic ◽  
Jelena Kostic ◽  
Sarlota Mesaros ◽  
Irena Dujmovic Basuroski ◽  
Nebojsa Stojsavljevic ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Interferon Beta ◽  
Disability Progression ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis

2013 ◽  
Vol 70 (2) ◽  
pp. 248 ◽  
Author(s):  
Benjamin M. Greenberg ◽  
Laura Balcer ◽  
Peter A. Calabresi ◽  
Bruce Cree ◽  
Anne Cross ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Interferon Beta ◽  
Disability Prevention ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis
Sign in / Sign up

Export Citation Format

Share Document